MCL coexpression mm9:419
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:75411037..75411078,+ | p1@Vpreb3 |
Mm9::chr10:75411080..75411098,+ | p2@Vpreb3 |
Mm9::chr11:44388716..44388720,+ | p@chr11:44388716..44388720 + |
Mm9::chr12:115045984..115045990,- | p1@LOC100047361 |
Mm9::chr12:115707771..115707799,- | p1@ENSMUST00000109711 |
Mm9::chr17:8437904..8437915,+ | p4@Ccr6 |
Mm9::chr17:8437919..8437957,+ | p1@Ccr6 |
Mm9::chr1:87497443..87497454,+ | p3@Gm2427 p3@Sp140 |
Mm9::chr2:99640370..99640374,+ | p@chr2:99640370..99640374 + |
Mm9::chr6:122503817..122503834,+ | p1@Aicda |
Mm9::chr6:67505591..67505606,+ | p1@ENSMUST00000103302 p1@uc012enb.1 |
Mm9::chr6:68101848..68101850,+ | p1@ENSMUST00000103318 |
Mm9::chr6:68424573..68424579,+ | p@chr6:68424573..68424579 + |
Mm9::chr6:68630341..68630348,+ | p1@ENSMUST00000103329 |
Mm9::chr6:68889550..68889579,+ | p1@ENSMUST00000103339 |
Mm9::chr6:70676952..70676959,- | p@chr6:70676952..70676959 - |
Mm9::chr9:103351500..103351511,- | p6@Bfsp2 |
Mm9::chr9:70664786..70664801,- | p@chr9:70664786..70664801 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0004126 | cytidine deaminase activity | 0.0361836203434129 |
GO:0004945 | angiotensin type II receptor activity | 0.0361836203434129 |
GO:0001595 | angiotensin receptor activity | 0.0361836203434129 |
GO:0016493 | C-C chemokine receptor activity | 0.0361836203434129 |
GO:0019957 | C-C chemokine binding | 0.0361836203434129 |
GO:0019239 | deaminase activity | 0.0361836203434129 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.0361836203434129 |
GO:0001637 | G-protein chemoattractant receptor activity | 0.0361836203434129 |
GO:0004950 | chemokine receptor activity | 0.0361836203434129 |
GO:0019956 | chemokine binding | 0.0361836203434129 |
GO:0005212 | structural constituent of eye lens | 0.0361836203434129 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 2.43e-23 | 6 |
megakaryocyte | 2.43e-23 | 6 |
megakaryocyte-erythroid progenitor cell | 2.19e-15 | 9 |
CD9-positive, CD41-positive megakaryocyte cell | 3.59e-12 | 3 |
Kit-positive, CD34-negative megakaryocyte erythroid progenitor cell | 3.59e-12 | 3 |
Kit-positive megakaryocyte progenitor cell | 3.59e-12 | 3 |
myeloid lineage restricted progenitor cell | 1.78e-10 | 13 |
myeloid cell | 2.12e-08 | 16 |
common myeloid progenitor | 5.61e-07 | 19 |
hematopoietic lineage restricted progenitor cell | 5.96e-07 | 25 |
Ontology term | p-value | n |
---|---|---|
hemolymphoid system | 2.44e-15 | 48 |
immune system | 2.44e-15 | 48 |
lymphoid system | 6.76e-13 | 3 |
spleen | 2.54e-10 | 6 |
cavity lining | 2.54e-10 | 6 |
serous membrane | 2.54e-10 | 6 |
gastrointestinal system mesentery | 2.54e-10 | 6 |
stomach region | 2.54e-10 | 6 |
mesentery | 2.54e-10 | 6 |
gastrointestinal system serosa | 2.54e-10 | 6 |
mesentery of stomach | 2.54e-10 | 6 |
gut mesentery | 2.54e-10 | 6 |
dorsal mesentery | 2.54e-10 | 6 |
dorsal mesogastrium | 2.54e-10 | 6 |
peritoneal cavity | 2.54e-10 | 6 |
spleen primordium | 2.54e-10 | 6 |
hematopoietic system | 4.96e-10 | 45 |
blood island | 4.96e-10 | 45 |
gut-associated lymphoid tissue | 2.80e-09 | 2 |
mucosa-associated lymphoid tissue | 2.80e-09 | 2 |
lymphoid tissue | 2.80e-09 | 2 |
intraembryonic coelom | 3.10e-09 | 10 |
bone marrow | 2.12e-08 | 16 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.000367447 |
MA0004.1 | 0.191582 |
MA0006.1 | 0.0854592 |
MA0007.1 | 1.02294 |
MA0009.1 | 0.5557 |
MA0014.1 | 0.00134458 |
MA0017.1 | 0.673859 |
MA0019.1 | 0.394308 |
MA0024.1 | 0.516087 |
MA0025.1 | 0.773017 |
MA0027.1 | 2.16618 |
MA0028.1 | 0.0910441 |
MA0029.1 | 0.496599 |
MA0030.1 | 0.502474 |
MA0031.1 | 0.470779 |
MA0038.1 | 0.815918 |
MA0040.1 | 1.39189 |
MA0041.1 | 0.140298 |
MA0042.1 | 0.412259 |
MA0043.1 | 0.644695 |
MA0046.1 | 1.43706 |
MA0048.1 | 0.0629374 |
MA0050.1 | 0.219748 |
MA0051.1 | 0.309072 |
MA0052.1 | 0.574473 |
MA0055.1 | 0.12934 |
MA0056.1 | 0 |
MA0057.1 | 0.0539481 |
MA0058.1 | 0.127732 |
MA0059.1 | 0.13543 |
MA0060.1 | 0.180016 |
MA0061.1 | 0.218812 |
MA0063.1 | 0 |
MA0066.1 | 0.293002 |
MA0067.1 | 0.879099 |
MA0068.1 | 0.309163 |
MA0069.1 | 0.574784 |
MA0070.1 | 0.565924 |
MA0071.1 | 0.219128 |
MA0072.1 | 0.558195 |
MA0073.1 | 0.0275581 |
MA0074.1 | 0.264633 |
MA0076.1 | 0.110983 |
MA0077.1 | 0.538513 |
MA0078.1 | 0.89286 |
MA0081.1 | 0.458627 |
MA0083.1 | 0.643958 |
MA0084.1 | 1.1979 |
MA0087.1 | 0.604077 |
MA0088.1 | 0.0849312 |
MA0089.1 | 0 |
MA0090.1 | 0.501796 |
MA0091.1 | 0.200988 |
MA0092.1 | 0.167962 |
MA0093.1 | 0.0955883 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.710522 |
MA0101.1 | 0.435524 |
MA0103.1 | 0.345124 |
MA0105.1 | 0.0222933 |
MA0106.1 | 0.342589 |
MA0107.1 | 0.335745 |
MA0108.2 | 0.413973 |
MA0109.1 | 0 |
MA0111.1 | 1.00863 |
MA0113.1 | 0.319332 |
MA0114.1 | 0.215695 |
MA0115.1 | 0.647296 |
MA0116.1 | 0.288992 |
MA0117.1 | 0.617392 |
MA0119.1 | 0.141504 |
MA0122.1 | 0.635764 |
MA0124.1 | 0.828115 |
MA0125.1 | 0.757653 |
MA0130.1 | 0 |
MA0131.1 | 0.390422 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.62559 |
MA0136.1 | 1.40201 |
MA0139.1 | 0.142421 |
MA0140.1 | 0.255562 |
MA0141.1 | 0.755244 |
MA0142.1 | 2.02095 |
MA0143.1 | 0.885347 |
MA0144.1 | 0.478562 |
MA0145.1 | 0.0329339 |
MA0146.1 | 0.0100022 |
MA0147.1 | 0.0666796 |
MA0148.1 | 0.587598 |
MA0149.1 | 0.144679 |
MA0062.2 | 0.0237736 |
MA0035.2 | 0.259203 |
MA0039.2 | 0.0352926 |
MA0138.2 | 0.383644 |
MA0002.2 | 0.611367 |
MA0137.2 | 0.747445 |
MA0104.2 | 0.0420926 |
MA0047.2 | 0.814521 |
MA0112.2 | 0.00604704 |
MA0065.2 | 0.372253 |
MA0150.1 | 0.53401 |
MA0151.1 | 0 |
MA0152.1 | 0.301303 |
MA0153.1 | 0.694211 |
MA0154.1 | 0.829187 |
MA0155.1 | 0.66805 |
MA0156.1 | 0.356573 |
MA0157.1 | 0.429861 |
MA0158.1 | 0 |
MA0159.1 | 0.250417 |
MA0160.1 | 0.592791 |
MA0161.1 | 0 |
MA0162.1 | 0.0145482 |
MA0163.1 | 0.0118116 |
MA0164.1 | 0.280556 |
MA0080.2 | 3.66779 |
MA0018.2 | 0.288261 |
MA0099.2 | 0.37828 |
MA0079.2 | 2.79101e-05 |
MA0102.2 | 1.24942 |
MA0258.1 | 0.0535937 |
MA0259.1 | 0.0616796 |
MA0442.1 | 0 |